Saniona's partner Cadent Therapeutics presents pre-clinical data on CAD-1883 at the National Ataxia Foundations meeting in Philadelphia
See the poster here
s
About Saniona
Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. The company has a significant portfolio of potential drug candidates at preclinical and clinical stage. The research is focused on ion channels, which makes up a unique protein class that enables and controls the passage of charged ions across cell membranes. Saniona has ongoing collaboration agreements with Boehringer Ingelheim GmbH, BenevolentAI, Productos Medix, S.A and Cadent Therapeutics. Saniona is based in Copenhagen, Denmark, where it has a research center of high international standard. Saniona is listed at Nasdaq Stockholm Small Cap and has about 5,300 shareholders. The company's share is traded under the ticker SANION.
Read more
Share Information
Saniona share (OMX: SANION) is listed on Nasdaq Stockholm Small Cap
Saniona's Pipeline Read more about our Saniona's Pipeline
We have a broad portfolio of potential drug candidates in preclinical or clinical stages.